Compare uniQure N.V. Ordinary Shares (QURE) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Wix.Com Ltd — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while Wix.Com Ltd trades at $74.3 (market cap $3.11B). The key difference: Wix.Com Ltd is far larger — about 2.1× uniQure N.V. Ordinary Shares's market cap, and Wix.Com Ltd is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Wix.Com Ltd for 62 Days on average.
| QURE | WIX | |
|---|---|---|
Market Cap | $1.45B | $3.11B |
Volume | 3,323,243 | 736,895 |
Sector | Health | Technology |
52-Week High | $70.59 | $145.54 |
52-Week Low | $9.03 | $40.43 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $707.46M | $4.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WIX trades at $71.74, down 3.28% today, amid a bearish technical signal and negative net cash flow. Revenue grew to $1.99B in 2025, but net income fell to $50.65M with a negative margin. Analyst consensus is bullish with a $77.00 price target, though recent class action lawsuits have dampened sentiment.
The outlook is mixed: strong revenue growth and analyst support offer upside, but profitability concerns, litigation risks, and negative equity pose significant challenges. Investors should weigh the high P/E ratio against potential operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
